 |
|
Deutsche Bank GECC GlaxoSmithKline EEB/TGI Bank of America |
In mid-August last year, it would have been difficult to find a bank that was not of the opinion that the credit crunch would be short-lived. Most were saying that the sub-prime troubles were relatively limited, and that the widening spreads and diminishing liquidity would come back soon, as they had during previous blips in the overall bull market of the past several years. But not everyone was so quick to dismiss the possibility of a prolonged problem.
Access intelligence that drives action
To unlock this research, enter your email to log in or enquire about access
